Skip to main content

Table 1 Basic characteristics of the enrolled patients

From: The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer

Variables No. (%)
Age (years)
  ≤ 50 77 (53)
  > 50 68 (47)
Pathologic T stage
 1 50 (35)
 2–4 95 (65)
Pathologic N stage
 0 54 (37)
 1–3 91 (63)
Histologic grade
 1–2 92 (64)
 3 53 (36)
Lymphovascular invasion
 Absent 86 (59)
 Present 59 (41)
Type of surgery
 Breast conserving surgery 35 (24)
 Mastectomy 110 (76)
Estrogen receptor
 Negative 64 (44)
 Positive 81 (56)
Progesterone receptor
 Negative 87 (60)
 Positive 58 (40)
HER2
 Negative 108 (75)
 Positive 37 (25)
Chemotherapy
 Neoadjuvant 44 (30)
 Adjuvant 95 (66)
 No 6 (4)
Adjuvant radiotherapy
 No 81 (56)
 Yes 64 (44)
  1. HER2, human epidermal growth factor receptor 2